期刊文献+

无溶剂悬乳剂3%双氟·唑草酮的开发 被引量:3

Development of Solvent-free Suspo-emulsion of Florasulam·Carfentrazone-ethyl 3% SE
原文传递
导出
摘要 [目的]采用不加入溶剂的方式制备悬乳剂,获得物性合格、生物活性优良的悬乳剂产品。[方法]筛选不同结构类型表面活性剂,通过配方工艺的调整,开发出3%双氟·唑草酮悬乳剂(SE),并对产品的制剂理化性能及生物活性进行研究。[结果]通过该技术的研究获得了性能指标优良、对猪殃殃的ED90值为3.6 g a.i./hm^2,明显优异于市售对照产品4.8 g a.i./hm^2的悬乳剂产品,探究了无溶剂悬乳剂开发的可能性。[结论]产品性能结果显示,分散稳定性合格,悬浮率为99%,其各项控制指标均符合悬乳剂的相关标准。生物活性数据表明,该制剂具有较优的生物活性,从环保意义和农药制剂探索方面均有重要意义。 [Aims] In this study, suspo-emulsion(SE) was prepared without solvent for the first time, and the SE product was obtained with qualified physical properties and excellent biological activity.[Methods] Florasulam·carfentrazoneethyl 3% SE was developed by screening different structures surfactants and adjusting the formulation process. The properties and biological activities of the product were studied.[Results] Through researching this technology, the SE product with good performance and the ED90 value for weeds is 3.6 g a.i./ha, significantly superior to commercially available control product 4.8 g a.i./ha, and the possibility of developing solvent-free SE was explored.[Conclusions] The results of the SE product showed that the dispersion stability is qualified, suspensibility is 99% and all the indicators met the relevant standards of SE. The biological activity showed that the product had excellent biological activity. It was of great significance in environmental protection and pesticide formulation technology exploration.
作者 遇璐 吴元华 崔东亮 丑靖宇 YU Lu;WU Yuan-hua;CUI Dong-liang;CHOU Jing-yu(State Key Laboratory of the Discovery and Development of Novel Pesticide,Shenyang Sinochem Agrochemicals R&D Co.,Ltd.,Shenyang 110021,China;College of Plant Protection,Shenyang Agricultural University,Shenyang 110866,China)
出处 《农药》 CAS CSCD 北大核心 2019年第8期576-579,共4页 Agrochemicals
基金 国家“十三五”项目:农药高效对靶载药体系设计与调控原理(2017YFD0200301)
关键词 无溶剂 悬乳剂 双氟·唑草酮 solvent-free suspo-emulsion florasulam·carfentrazone
  • 相关文献

参考文献3

二级参考文献29

  • 1朱建芬,吴祥根.纳米混悬剂的制备方法及在药剂学中应用的研究进展[J].中国医药工业杂志,2006,37(3):196-200. 被引量:38
  • 2吕文彦,娄国强.苯磺隆、绿麦隆混用最佳配比防除麦田杂草技术研究[J].河南农业大学学报,2007,41(1):93-98. 被引量:6
  • 3RH Muller, R Becker, B Kruss, et al. Pharmaceutical nanosuspensions for medicament administration as systems with increased saturation solubility and rate of solution[P]. United States Patent 5,858,410, Medac Geseitschaft far Klinische Spezialpraparate mbH, 1999.
  • 4Claudia Jacobs, Rainer Helmut Muller. Production and characterization of a budesonide nanosuspension for pulmonary administration[J]. Pharm Res, 2002,19(2): 189-194.
  • 5C Jacobs, O Kayser, RH Mfiller. Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide[J]. Int J Pharm, 2000, 196(2) : 161-164.
  • 6K Peters, S Leitzke, JE Diederichs, et al. Preparation of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection[J]. J Antimicrob Chemother, 2000, 45 (1) : 77-83.
  • 7KP Krause, O Kayser, K Mader, et al. Heavy metal contamination of nanosuspensions produced by high-pressure homogenisation[J]. Int J Pharrn,2000,196(2) : 169-172.
  • 8JE Kipp, Wong, JCT, et al. Microprecipitation Method For Preparing Submieron Suspensions[P]. United States Patent 6,607,784, Baxter International Inc. (Deerfield, IL), USA, 2003.
  • 9Henriksen, Mishra, Pace, et al. Insoluble drug delievery[P], International Patent 97/14407, Triangle Pharmaceuticals, The university of Texas system, April 24,1997.
  • 10James E. Kipp, Mark J. Doty,CL. Rebbeck, etal. Compositions of and Method for Preparing Stable Partieiles in a Frozen Aqueous Matrix[P], United States Patent 7,112,340, Baxter International Inc. (Deerfield, IL) Sep. 26, 2006.

共引文献20

同被引文献28

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部